U.S., July 10 -- ClinicalTrials.gov registry received information related to the study (NCT07056673) titled 'Cold Atmospheric Plasma for Moderate-to-severe Acne Vulgaris Study' on June 30.
Brief Summary: Acne vulgaris is a common, chronic inflammatory skin disease with complex pathogenesis and limited therapeutic options, especially for moderate-to-severe cases. Standard treatments-including topical and oral agents-are often constrained by side effects, antimicrobial resistance, and treatment resistance. Cold atmospheric plasma (CAP), a novel technology that generates reactive oxygen and nitrogen species, has demonstrated antimicrobial and tissue-regenerative properties in dermatology, but robust clinical evidence in acne management remain...